Benefit with enfortumab vedotin confirmed

Nat Rev Clin Oncol. 2021 May;18(5):258. doi: 10.1038/s41571-021-00493-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • B7-H1 Antigen*
  • Humans

Substances

  • Antibodies, Monoclonal
  • B7-H1 Antigen
  • enfortumab vedotin